InVivo Therapeutics Reports Third Quarter 2011 Financial Results, Provides Business Update

print this article - email to a friend - join our eNewsletter
Submitted by admin on 11/15/2011 @ 3:00 AM
Companies mentioned in this article: InVivo Therapeutics Holdings Corp.

CAMBRIDGE, Mass. -- (BUSINESS WIRE) -- InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.

The Company’s biopolymer scaffold technology is designed to provide structural support for a damaged spinal cord to promote healing and improve functional recovery and prognosis for SCI patients. Today there is no effective treatment for the spinal cord for paralysis caused by SCIs, and the annual market potential is estimated to be over $10 Billion.

Financial Results